InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (18 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
18
T+90 hit rate
0%
T+90 mean return
-36.1%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by SUN ANTHONY Y, Chief Executive Officer. Director active across 2 companies, notably Zentalis Pharmaceuticals, Inc.. Aggregated, 29 filings have been recorded. Split: 0 buy · 18 sells. Total volume traded: €9.3m. Activity tracked since 21 April 2021. The latest transaction was disclosed on 4 April 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations29 total
10,471 shares@ US$48.500.16% mcap5.0% of flowCommon StockSEC:0001725160-22-000068:0
8,771 shares@ US$49.74320.13% mcap4.2% of flowCommon StockSEC:0001725160-22-000055:0
50,431 shares0Common StockSEC:0001725160-22-000031:0
4,124 shares@ US$56.80960.072% mcap2.2% of flowCommon StockSEC:0001725160-22-000017:0
4,124 shares@ US$56.80960.072% mcap4.9% of flowCommon StockSEC:0001725160-22-000017
15,000 shares0Common StockSEC:0001725160-22-000006
15,000 shares0Common StockSEC:0001725160-22-000006:0
125,000 shares0Common StockSEC:0001725160-21-000236:0
125,000 shares0Common StockSEC:0001725160-21-000236
125,000 shares0Common StockSEC:0001725160-21-000232:0
125,000 shares0Common StockSEC:0001725160-21-000232
6,963 shares0Common Stock, par value $.0001SEC:0001415889-21-005363:0
6,963 shares0Common Stock, par value $.0001SEC:0001415889-21-005363
4,420 shares@ US$80.7233.3% of flowCommon StockSEC:0001725160-21-000211
4,420 shares@ US$80.7230.11% mcap3.3% of flowCommon StockSEC:0001725160-21-000211:0
10,464 shares@ US$65.95340.21% mcap6.4% of flowCommon StockSEC:0001725160-21-000198:0
10,464 shares@ US$65.95346.4% of flowCommon StockSEC:0001725160-21-000198
12,487 shares@ US$67.09420.25% mcap7.6% of flowCommon StockSEC:0001725160-21-000190:0
12,487 shares@ US$67.09427.6% of flowCommon StockSEC:0001725160-21-000190
6,900 shares@ US$50.01040.10% mcap3.1% of flowCommon StockSEC:0001725160-21-000176:0
6,900 shares@ US$50.01043.1% of flowCommon StockSEC:0001725160-21-000176
19,348 shares@ US$46.78260.27% mcap8.2% of flowCommon StockSEC:0001725160-21-000170:0
19,348 shares@ US$46.78268.2% of flowCommon StockSEC:0001725160-21-000170
7,349 shares@ US$50.17183.3% of flowCommon StockSEC:0001725160-21-000162
7,349 shares@ US$50.17180.11% mcap3.3% of flowCommon StockSEC:0001725160-21-000162:0
25 of 29 declarations
About SUN ANTHONY Y
Anthony Y Sun is an executive at Zentalis Pharmaceuticals, Inc.
